IN2012DE00728A - - Google Patents

Download PDF

Info

Publication number
IN2012DE00728A
IN2012DE00728A IN728DE2012A IN2012DE00728A IN 2012DE00728 A IN2012DE00728 A IN 2012DE00728A IN 728DE2012 A IN728DE2012 A IN 728DE2012A IN 2012DE00728 A IN2012DE00728 A IN 2012DE00728A
Authority
IN
India
Prior art keywords
solution
organic solvent
heating
imatinib mesylate
clear solution
Prior art date
Application number
Other languages
English (en)
Inventor
Aswini Kumar Sharma
Abhishek Giri
Tapanjyoti Biswal
Govind Singh
Saswata Lahiri
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Priority to IN728DE2012 priority Critical patent/IN2012DE00728A/en
Priority to PCT/IB2012/054240 priority patent/WO2013136141A1/en
Publication of IN2012DE00728A publication Critical patent/IN2012DE00728A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN728DE2012 2012-03-13 2012-08-22 IN2012DE00728A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN728DE2012 IN2012DE00728A (ja) 2012-03-13 2012-08-22
PCT/IB2012/054240 WO2013136141A1 (en) 2012-03-13 2012-08-22 An improved process for the preparation of alpha form of imatinib mesylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN728DE2012 IN2012DE00728A (ja) 2012-03-13 2012-08-22

Publications (1)

Publication Number Publication Date
IN2012DE00728A true IN2012DE00728A (ja) 2015-08-21

Family

ID=47010664

Family Applications (1)

Application Number Title Priority Date Filing Date
IN728DE2012 IN2012DE00728A (ja) 2012-03-13 2012-08-22

Country Status (2)

Country Link
IN (1) IN2012DE00728A (ja)
WO (1) WO2013136141A1 (ja)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW225528B (ja) 1992-04-03 1994-06-21 Ciba Geigy Ag
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
PT1720853E (pt) 2004-02-11 2016-03-04 Natco Pharma Ltd Nova forma polimórfica de mesilato de imatinib e processo para a sua preparação
UA84462C2 (ru) * 2004-04-02 2008-10-27 Институт Фармацевтични Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой
US8269003B2 (en) 2004-09-02 2012-09-18 Cipla Limited Stable crystal form of imatinib mesylate and process for the preparation thereof
WO2006048890A1 (en) 2004-11-04 2006-05-11 Sun Pharmaceutical Industries Limited Imatinib mesylate crystal form and process for preparation thereof
BRPI0702877A2 (pt) 2006-04-27 2015-07-07 Ivax Pharmaceuticals S R O E Teva Pharmaceutical Usa Inc Formas polimórficas de mesilato de imatinib, processo para o novo preparo de novas formas cristalinas, amorfas e forma alfa, composições farmacêuticas correlatas, seus processos de preparo e uso
US20060223816A1 (en) 2006-05-08 2006-10-05 Chemagis Ltd. Imatinib mesylate alpha form and production process therefor
US7550591B2 (en) 2007-05-02 2009-06-23 Chemagis Ltd. Imatinib production process
EP2291366A4 (en) 2008-05-26 2012-06-06 Reddys Lab Ltd Dr PREPARATION OF IMATINIB MESYLATE
PL215042B1 (pl) * 2008-08-01 2013-10-31 Temapharm Spolka Z Ograniczona Odpowiedzialnoscia Sposób wytwarzania imatinibu
US20100330130A1 (en) 2009-05-22 2010-12-30 Actavis Group Ptc Ehf Substantially pure imatinib or a pharmaceutically acceptable salt thereof
AU2011213936A1 (en) 2010-02-15 2012-09-06 Sharma Ashwani Process for the preparation of alpha form of imatinib mesylate
PL390611A1 (pl) 2010-03-04 2011-09-12 Tomasz Koźluk Sposób otrzymywania polimorficznej formy alfa i nowa forma polimorficzna mesylanu imatinibu
WO2011158255A1 (en) 2010-06-16 2011-12-22 Aptuit Laurus Private Limited Process for preparation of stable imatintb mesylate alpha form
SI2582689T1 (sl) 2010-06-18 2017-05-31 Krka, D.D., Novo Mesto Nova polimorfna oblika imatinib baze in priprava njenih soli
CN102190649B (zh) * 2011-03-28 2013-01-02 齐鲁天和惠世制药有限公司 一种制备α型甲磺酸伊马替尼的方法

Also Published As

Publication number Publication date
WO2013136141A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
ECSP18010065A (es) Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol
NZ734451A (en) Preparation, uses and solid forms of obeticholic acid
MD20120129A2 (en) Process for the preparation of perindopril L-arginine salt
MY167395A (en) Method for producing glufosinate p free acid
CO6541539A2 (es) Procesos para preparar las formas cristalinas a y b de ilaprazol y proceso para convertir las formas cristalinas
TR201907789T4 (tr) Kalkobutrol hazirlanişina yöneli̇k yöntem
RS54201B1 (en) PROCEDURE FOR PREPARATION OF BIFENYL-2-ILCARBAMIC ACID
NZ724923A (en) Crystalline forms of grapiprant
IN2014DN02166A (ja)
AR117002A2 (es) Proceso para la preparación de inhibidores de quinasa c-fms
EP3760637A3 (en) Stable solid forms of regadenoson
IN2014MN02314A (ja)
BR112019000291A2 (pt) processos inovadores para a preparação de estimuladores de guanilato ciclase solúvel
WO2014125270A8 (en) Process for preparing atazanavir sulphate
IN2014KN02722A (ja)
IN2012DE00728A (ja)
BR112016024977A2 (pt) processo para a preparação de polimorfos de imidacloprida
WO2010140132A8 (en) Process for the preparation of crystalline aprepitant having form i content
GEP20156350B (en) New process for synthesis of ivabradine and their additional salts with pharmaceutically acceptable acid
AR090844A1 (es) Proceso para elaborar derivados de naftiridina
MX2010007923A (es) Forma cristalina de abacavir que esta esencialmente libre de disolvente.
WO2015188243A9 (en) PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
IN2013MU03508A (ja)
NZ705677A (en) An improved process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-amino-2,5-dimethoxypyrimidine